X0609 4 2026-06-05 0001674416 CRISPR Therapeutics AG CRSP 0001559231 Fardis Maria false C/O CRISPR THERAPEUTICS 105 WEST FIRST STREET BOSTON MA 02127 true false false false false Stock Option (Right to Buy) 51.84 2026-06-05 4 A false 13000 0 A 2036-06-05 Common Shares 13000 13000 D Subject to continued service to the Company or any of its subsidiaries, the options will vest and become exercisable in 12 equal monthly installments on the final day of each succeeding calendar month occurring after the grant date provided that the first installment vests on June 30, 2026 and the last installment vests on the earlier of (i) the one year anniversary of the date of grant or (ii) the date of the 2027 Annual Meeting. /s/ Elizabeth Ryland Waldinger 2026-06-09